ALIGN TECHNOLOGY, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
ALIGN TECHNOLOGY, INC. (ALGN) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$3.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$3.51M, a 108.15% decline year-over-year.
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$5.29M, a 143.41% decline year-over-year.
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $10.02M.
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $4.18M, a 61.51% decline year-over-year.
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $69.41M.
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$15.19M, a 148.30% decline from fiscal 2023.
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $31.45M.
- ALIGN TECHNOLOGY, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$14.61M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.51M 10-Q · filed 2026-08-05 | -$8.80M 10-Q · filed 2026-08-05 | $1.21M derived: sum of 3 quarters · filed 2026-08-05 | $5.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$5.29M 10-Q · filed 2026-05-06 | $4.72M derived: sum of 2 quarters · filed 2026-05-06 | $8.91M derived: sum of 3 quarters · filed 2026-05-06 | $51.92M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $10.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $14.20M derived: sum of 2 quarters · filed 2026-02-27 | $57.21M derived: sum of 3 quarters · filed 2026-08-05 | $69.41M 10-K · filed 2026-02-27 |
| 2025-09-30 | $4.18M 10-Q · filed 2025-11-05 | $47.20M derived: sum of 2 quarters · filed 2026-08-05 | $59.39M 10-Q · filed 2025-11-05 | $29.46M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $43.01M 10-Q · filed 2026-08-05 | $55.21M 10-Q · filed 2026-08-05 | $25.27M derived: sum of 3 quarters · filed 2026-08-05 | $36.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $12.20M 10-Q · filed 2026-05-06 | -$17.74M derived: sum of 2 quarters · filed 2026-05-06 | -$6.86M derived: sum of 3 quarters · filed 2026-05-06 | -$262.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$29.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$19.06M derived: sum of 2 quarters · filed 2026-02-27 | -$12.46M derived: sum of 3 quarters · filed 2026-02-27 | -$15.19M 10-K · filed 2026-02-27 |
| 2024-09-30 | $10.87M 10-Q · filed 2025-11-05 | $17.47M derived: sum of 2 quarters · filed 2025-11-05 | $14.74M 10-Q · filed 2025-11-05 | $33.87M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $6.60M 10-Q · filed 2025-08-06 | $3.87M 10-Q · filed 2025-08-06 | $22.99M derived: sum of 3 quarters · filed 2026-02-27 | $13.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$2.73M 10-Q · filed 2025-05-08 | $16.39M derived: sum of 2 quarters · filed 2026-02-27 | $7.10M derived: sum of 3 quarters · filed 2026-02-27 | $16.60M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $19.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.82M derived: sum of 2 quarters · filed 2026-02-27 | $19.33M derived: sum of 3 quarters · filed 2026-02-27 | $31.45M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$9.30M 10-Q · filed 2024-11-05 | $212.00K derived: sum of 2 quarters · filed 2024-11-05 | $12.33M 10-Q · filed 2024-11-05 | $42.79M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $9.51M 10-Q · filed 2024-08-02 | $21.63M 10-Q · filed 2024-08-02 | $52.09M derived: sum of 3 quarters · filed 2025-02-28 | $31.11M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $12.12M 10-Q · filed 2024-05-03 | $42.58M derived: sum of 2 quarters · filed 2025-02-28 | $21.61M derived: sum of 3 quarters · filed 2025-02-28 | $7.55M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $30.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $9.49M derived: sum of 2 quarters · filed 2025-02-28 | -$4.57M derived: sum of 3 quarters · filed 2025-02-28 | -$14.61M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$20.98M 10-Q · filed 2023-11-03 | -$35.03M derived: sum of 2 quarters · filed 2023-11-03 | -$45.07M 10-Q · filed 2023-11-03 | -$58.34M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$14.06M 10-Q · filed 2023-08-04 | -$24.10M 10-Q · filed 2023-08-04 | -$37.37M derived: sum of 3 quarters · filed 2024-02-28 | -$49.39M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$10.04M 10-Q · filed 2023-05-05 | -$23.31M derived: sum of 2 quarters · filed 2024-02-28 | -$35.33M derived: sum of 3 quarters · filed 2024-02-28 | -$34.74M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$13.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$25.29M derived: sum of 2 quarters · filed 2024-02-28 | -$24.70M derived: sum of 3 quarters · filed 2024-02-28 | -$39.17M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$12.02M 10-Q · filed 2022-11-04 | -$11.43M derived: sum of 2 quarters · filed 2022-11-04 | -$25.90M 10-Q · filed 2022-11-04 | -$7.31M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $586.00K 10-Q · filed 2022-08-04 | -$13.88M 10-Q · filed 2022-08-04 | $4.71M derived: sum of 3 quarters · filed 2023-02-27 | $20.52M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$14.47M 10-Q · filed 2022-05-05 | $4.12M derived: sum of 2 quarters · filed 2023-02-27 | $19.93M derived: sum of 3 quarters · filed 2023-02-27 | $29.22M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $18.59M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $34.40M derived: sum of 2 quarters · filed 2023-02-27 | $43.69M derived: sum of 3 quarters · filed 2023-02-27 | $44.19M 10-K · filed 2023-02-27 |
| 2020-09-30 | $15.81M 10-Q · filed 2021-11-02 | $25.10M derived: sum of 2 quarters · filed 2021-11-02 | $25.60M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $9.29M 10-Q · filed 2021-08-04 | $9.79M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $495.00K 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $2.09M 10-K · filed 2022-02-25 | |||
| 2018-12-31 | -$3.35M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $1.51M 10-K · filed 2020-02-28 | |||
| 2016-12-31 | $42.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | -$840.00K 10-K · filed 2018-02-28 | |||
| 2014-12-31 | -$434.00K 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $91.00K 10-K · filed 2016-02-25 | |||
| 2012-12-31 | $157.00K 10-K · filed 2015-02-26 | |||
| 2011-12-31 | -$88.00K 10-K · filed 2014-02-28 | |||
| 2010-12-31 | -$321.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |